Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres

References

• Capan Y, Woo BH, Gebrekidan S, Ahmed S, Delucap P. Influence of formulation parameters on the characteristics of poly(D,L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA. J Contr Rel 1999; 60: 279–286
   PubMed Web of Science ®Google Scholar
• Charley B, Riffault S, Van Reeth K. Porcine innate and adaptative immune responses to influenza and coronavirus infections. Ann NY Acad Sci 2006; 1081: 130–136
   PubMed Web of Science ®Google Scholar
• Chen Y, Xin XG, Yang HL, Li T, Li HY, Qiao CL, et al. Establishment of an indirect ELISA for detection of antibodies against swine influenza virus. Chin J Prev Vet Med 2007; 29: 308–311
   Google Scholar
• Chen YJ, Xu XY, Zhou JP. Research advance in PLGA microspheres. J Chin Pharm Uni 2007; 38: 186–189
   Google Scholar
• Cohen S, Chen L, Apte RN. Controlled release of peptides and proteins from biodegradable polyester microspheres: An approach for treating infectious disease and malignancies. React Polym 1995; 25: 177–187
   Google Scholar
• Denis-Mize KS, Dupuis M, MacKichan ML, Singh M, Doe B, O’Hagan D, et al. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Ther 2000; 7: 2105–2112
   PubMed Web of Science ®Google Scholar
• Dhama K, Mahendran M, Gupta PK, Rai A. DNA vaccines and their applications in veterinary practice: Current perspectives. Vet Res Commun 2008; 32: 341–356
   PubMed Web of Science ®Google Scholar
• Donnelly JJ, Wahren B, Liu MA. DNA vaccines: Progress and challenges. J Immunol 2005; 175: 633–639
   PubMed Web of Science ®Google Scholar
• Dubensky TW, Liu MA, Ulmer JB. Delivery systems for gene-based vaccines. Mol Med 2000; 6: 723–732
   PubMed Web of Science ®Google Scholar
• Forde GM. Rapid-response vaccines-does DNA offer a solution?. Nat Biotechnol 2005; 23: 1059–1062
   PubMed Web of Science ®Google Scholar
• Gray GC, Baker WS. The importance of including swine and poultry workers in influenza vaccination programs. Clin Pharmacol Ther 2007; 82: 638–641
   PubMed Web of Science ®Google Scholar
• He XW, Wang F, Jiang L, Li J, Liu SK, Xiao ZY, et al. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg. J Gen Virol 2005; 86: 601–610
   PubMed Web of Science ®Google Scholar
• Hou F. Ectopic intramuscular expression of Ghrelin and GRF gene leads to mouse body weight gain. Masters Degree Thesis. Department of Biochemistry and Molecular Biology, Jilin University, China Apr., 2007; 51
   Google Scholar
• Hyejung M, Tae GP. Direct plasmid DNA encapsulation within PLGA nanospheres by single oil-in-water emulsion method. Eur J Pharm Biopharm 2008; 68: 105–111
   PubMed Web of Science ®Google Scholar
• Jae-Hyung J, Lonnie DS. Intramuscular delivery of DNA releasing microspheres: Microsphere properties and transgene expression. J Contr Rel 2006; 112: 120–128
   PubMed Web of Science ®Google Scholar
• Jin HL, Li YJ, Ma ZH, Zhang FC, Xie QG, Gu DF, et al. Effect of chemical adjuvants on DNA vaccination. Vaccine 2004; 22: 2925–2935
   PubMed Web of Science ®Google Scholar
• Kavanagh OV, Earley B, Murray M, Foster CJ, Adair BM. Antigenspecific IgA and IgG responses in calves inoculated intranasally with ovalbumin encapsulated in poly D, L-lactide-co-glycolide microspheres. Vaccine 2003; 21: 4472–4480
   PubMed Web of Science ®Google Scholar
• Kim SY, Doh HJ, Ahn JS, Ha YJ, Jang MH, Chung SI, et al. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly D,L-lactide-co-glycolide microparticles. Vaccine 1999; 17: 607–616
   PubMed Web of Science ®Google Scholar
• Kothalawala H, Toussaint MJM, Gruys E. An overview of swine influenza. Vet Q 2006; 28: 45–53
   Web of Science ®Google Scholar
• Laddy DJ, Weiner DB. From plasmids to protection: A review of DNA vaccines against infectious diseases. Int Rev Immunol 2006; 25: 99–123
   PubMed Web of Science ®Google Scholar
• Larsen DL, Karasin A, Olsen CW. Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting. Vaccine 2001; 19(20–22)2842–53
   PubMed Web of Science ®Google Scholar
• Lee JH, Gramer MR, Joo HS. Efficacy of swine influenza A virus vaccines against an H3N2 virus variant. Can J Vet Res 2007; 71: 207–212
   PubMed Web of Science ®Google Scholar
• Li GX, Qiu HJ, Han CG, Han LX, Zhou YJ, Chen Y, et al. Vaccination of plasmid DNA encoding somatostatin gene fused with GP5 gene of porcine reproductive and respiratory syndrome virus induces anti-GP5 antibodies and promotes growth performance in immunized pigs. Sci Agric Sin 2006; 5: 234–240
   Google Scholar
• Li GX, Tian ZJ, Yu H, Jin YY, Hou SH, Zhou YJ, et al. Fusion of C3d with hemagglutinin enhances protective immunity against swine influenza virus. Res Vet Sci 2008; 86: 406–413
   PubMed Web of Science ®Google Scholar
• Liu Y, Deng X. Influence of preparation conditions on particle size and DNA-loading efficiency for poly (DL-lactic-polyethylene glycol) microspheres entrapping free DNA. J Contr Rel 2002; 83: 147–155
   PubMed Web of Science ®Google Scholar
• Maheshwari A, Han S, Mahato RI, Kim SW. Biodegradable polymer based interleukin-12 gene delivery: Role of induced cytokines, tumor infiltrating cells and nitric oxide in anti-tumor activity. Gene Ther 2002; 9: 1075–1084
   PubMed Web of Science ®Google Scholar
• Manca ML, Mourtas S, Dracopoulos V. PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization. Colloids Surf B Biointerfaces 2008; 62: 220–231
   PubMed Web of Science ®Google Scholar
• Mathew T, Mahendran M, Dhama K, Kataria JM, Kothawala H, Gruys E. Swine influenza. (Chapter VI). Advances in medical and veterinary virology, immunology and epidemiology. Vol. 6: Influenza and it's global public health significance, MM Tripathi, M Thankam. Thajema Publishers, West Orange, NJ 2006; 94–111
   Google Scholar
• Meeusen Els NT, Walker J, Peters A, Pastoret PP, Jungersen G. Current status of veterinary vaccines. Clin Microbiol Rev 2007; 20: 489–510
   PubMed Web of Science ®Google Scholar
• Mok H, Park TG. Direct plasmid DNA encapsulation within PLGA microspheres by single oil-in-water emulsion method. Eur J Pharm Biopharm 2008; 68: 105–111
   PubMed Web of Science ®Google Scholar
• Mollenkopfa HJ, Dietrichb G, Fensterlea J, Grodea L, Diehlb KD, Knappb B, et al. Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles. Vaccine 2004; 22: 2690–2695
   PubMed Web of Science ®Google Scholar
• Newman KD, Elamanchili P, Kwon GS, Samuel J. Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigenpresenting cells in vivo. J Biomed Mater Res 2002; 60: 480–486
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, Singh M. Microparticles as vaccine adjuvants and delivery systems. Expert Rev Vaccines 2003; 2: 269–283
   PubMedGoogle Scholar
• Pachuk CJ, Mccallus DE, Weiner DB, Satishchandran C. DNA vaccines—challenges in delivery. Curr Opin Mol Ther 2000; 2: 188–198
   PubMed Web of Science ®Google Scholar
• Parka IK, Kim TH, Kim SI, Park YH, Kim WJ, Akaike T, et al. Visualization of transfection of hepatocytes by galactosylated chitosan-graft-poly(ethylene glycol)/DNA complexes by confocal laser scanning microscopy. Int J Pharm 2003; 257: 103–110
   PubMed Web of Science ®Google Scholar
• Robertson JS, Griffiths E. Assuring the quality, safety and efficacy of DNA vaccines. Mol Biotechnol 2001; 17: 143–149
   PubMed Web of Science ®Google Scholar
• Rouse J, Mohamed F, van der Walle CF. Physical ageing and thermal analysis of PLGA microspheres encapsulating protein or DNA. Int J Pharm 2007; 2: 112–120
   Google Scholar
• Ruberti M, De Melo LK, Dos Santos SA, Brandao IT, Soares EG, Silva CL, et al. Prime-boost vaccination based on DNA and protein-loaded microspheres for tuberculosis prevention. J Drug Target 2004; 12: 195–203
   PubMed Web of Science ®Google Scholar
• Sales-Junior PA, Guzman F, Vargas MI, Sossai S, Patarroyo VAM, González CZL, et al. Use of biodegradable PLGA microspheres as a slow release delivery system for the Boophilus microplus synthetic vaccine SBm7462. Vet Immunol Immunopathol 2005; 107: 281–290
   PubMed Web of Science ®Google Scholar
• Sharpe S, Hanke T, Tinsley-Bown A, Dennis M, Dowall S, McMichael A, et al. Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara. Virology 2003; 13: 13–21
   Google Scholar
• Singh M, Kazzaz J, Ugozzoli M, Chesko J, O’Hagan DT. Charged polylactide co-glycolide microparticles as antigen delivery systems. Expert Opin Biol Ther 2004; 4: 483–491
   PubMed Web of Science ®Google Scholar
• Singh M, O’Hagan DT. Recent advances in vaccine adjvants. Pharm Res 2002; 19: 715–720
   PubMed Web of Science ®Google Scholar
• Song RJ, Liu SQ, Robert J. Adams, Kam WL. Enhancing efficacy of HIV Gag DNA vaccine by local delivery of GM-CSF in murine and macaque models. J Interferon Cytokine Res 2006; 26: 380–389
   PubMed Web of Science ®Google Scholar
• Sudhir PK, Karishma S, Krishnendu R. Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines. Biomaterials 2005; 5: 6375–6385
   Google Scholar
• Thacker E, Janke B. Swine influenza virus: Zoonotic potential and vaccination strategies for the control of avian and swine influenzas. J Infect Dis 2008; 197: 19–24
   Web of Science ®Google Scholar
• Tian ZJ, Zhou GH, Zheng BL, Qiu HJ, Ni JQ, Yang HL, et al. A recombinant pseudorabies virus encoding the HA gene from H3N2 subtype swine influenza virus protects mice from virulent challenge. Vet Immunol Immunopathol 2006; 111: 211–218
   PubMed Web of Science ®Google Scholar
• Tinsley-Bown AM, Fretwell R, Dowsett AB, Davis SL, Farrar GH. Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. J Contr Rel 2000; 66: 229–241
   PubMed Web of Science ®Google Scholar
• Vannie P, Capua I, Le Potier MF, Mackay DK, Muylkens B, et al. Marker vaccines and the impact of their use on diagnosis and prophylactic measures. Rev Sci Tech 2007; 26: 351–372
   PubMed Web of Science ®Google Scholar
• Vincent AL, Ma W, Lager KM, Janke BH, Webby RJ, Garcia-Sastre A, et al. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. Vaccine 2007; 25: 7999–8009
   PubMed Web of Science ®Google Scholar
• Wang D, Robinson DR, Kwon GS, Samuel J. Encapsulation of plasmid DNA in biodegradable poly(D,L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J Contr Rel 1999; 57: 9–18
   PubMed Web of Science ®Google Scholar
• Wang ZR, Xu QY, Ye YQ. Research progress on preparative parameters that influence the characteristics of PLA/PLGA/PELA microspheres prepared by double emulsion method. Int J Biomed Eng 2004; 29: 238–242
   Google Scholar
• Zhou SB, Liao XY, Li XH, Deng XM, Li HM. Poly-DL-lactide-poly (ethylene glycol) microspheres as potential vaccine delivery system. J Contr Rel 2003; 86: 195–205
   PubMed Web of Science ®Google Scholar